Cargando…
Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study
OBJECTIVE: To compare changes in bone mineral density (BMD) in rheumatoid arthritis (RA) patients receiving three-year conventional synthetic disease-modifying anti-rheumatic drugs (csDMARD), tumor necrosis factor-α inhibitors (TNFi), and abatacept. METHODS: Patients with RA were recruited from Sept...
Autores principales: | Chen, Ming-Han, Yu, Shan-Fu, Chen, Jia-Feng, Chen, Wei-Sheng, Liou, The-Ling, Chou, Chung-Tei, Hsu, Chung-Yuan, Lai, Han-Ming, Chen, Ying-Chou, Tsai, Chang-Youh, Cheng, Tien-Tsai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720866/ https://www.ncbi.nlm.nih.gov/pubmed/34987510 http://dx.doi.org/10.3389/fimmu.2021.783030 |
Ejemplares similares
-
The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis—A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study
por: Yu, Shan-Fu, et al.
Publicado: (2022) -
Biological tapering and sonographic flare in rheumatoid arthritis
por: Ko, Chi-Hua, et al.
Publicado: (2018) -
Establishment of a preliminary FRAX®-based intervention threshold for
rheumatoid arthritis–associated fragility fracture: a 3-year longitudinal,
observational, cohort study
por: Yu, Shan-Fu, et al.
Publicado: (2022) -
The impact of low-dose glucocorticoids on disease activity, bone mineral density, fragility fractures, and 10-year probability of fractures in patients with rheumatoid arthritis
por: Cheng, Tien-Tsai, et al.
Publicado: (2018) -
Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes
por: Hsu, Chung-Yuan, et al.
Publicado: (2020)